SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001485003-23-000092
Filing Date
2023-02-28
Accepted
2023-02-28 08:07:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 425 sesnformfy2022earningsrele.htm 425 28108
2 EX-99.1 a20230228_4q2022earnings.htm EX-99.1 28229
3 a20230228_4q2022earnings001.jpg GRAPHIC 229752
4 a20230228_4q2022earnings002.jpg GRAPHIC 283209
5 a20230228_4q2022earnings003.jpg GRAPHIC 303470
6 a20230228_4q2022earnings004.jpg GRAPHIC 291179
7 a20230228_4q2022earnings005.jpg GRAPHIC 338612
8 a20230228_4q2022earnings006.jpg GRAPHIC 308454
9 a20230228_4q2022earnings007.jpg GRAPHIC 127167
10 a20230228_4q2022earnings008.jpg GRAPHIC 125047
11 a20230228_4q2022earnings009.jpg GRAPHIC 110487
  Complete submission text file 0001485003-23-000092.txt   2975215
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filed by) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36296 | Film No.: 23678522
SIC: 2834 Pharmaceutical Preparations